ACM
COYA icon

ADAR1 Capital Management’s Coya Therapeutics COYA Stock Holding History

ADAR1 Capital Management’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$161K Buy
+40,900
New +$191K 0.01% 269

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

ADAR1 Capital Management's COYA Position: Q1 2026 in Review

ADAR1 Capital Management opened a new position in Coya Therapeutics (COYA) in Q1 2026: 40,900 shares worth $161K. The stake represents 0.01% of the portfolio and ranks #269 among its holdings.

56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • ADAR1 Capital Management held 40,900 shares of Coya Therapeutics worth $161K as of Q1 2026.
  • Coya Therapeutics was a new ADAR1 Capital Management position in Q1 2026.
  • Coya Therapeutics made up 0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #269 holding.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.